iShares MSCI Denmark ETF

Novo Nordisk Shares Drop 15% as Weight Loss Drug Fails to Compete with Eli Lilly’s Breakthrough in Latest Trial

Novo Nordisk’s stock dropped by 15% on Monday after news that its weight-loss drug, CagriSema, did not meet its main ... Read more